Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Generex Provides Access Information for Investor Conference Call Scheduled for January 4, 2018

Generex Biotechnology Corporation
Posted on: 03 Jan 18

Generex Biotechnology Corporation (OTCQB:GNBT) ( ( today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time:


Toll Free:





The purpose of the conference call is to provide Company stockholders and other interested parties with an update in respect of the Company’s initiatives and strategic plans.

View source version on

Business Wire

Last updated on: 03/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.